comparision of mangosteen and moringa oliefera gel with DFDBA individually in participants with intrabony defects

Comparison of Mangosteen gel and Moringa oliefera gel with Demineralised freeze dried bone allograft in the treatment of intrabony defects - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092785

Enrollment

Registered

2025-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: mangosteen gel with DFDBA: 6 to 7 months Control Intervention1: Moringa oliefera gel with DFDBA: 6 to 7 months

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having periodontal pocket depth of greater than or equal to 5mm. 2) Clinical attachment loss of greater than or equal to 3mm. 3) Radiographic evidence of intrabony defects

Exclusion criteria

Exclusion criteria: 1)Those who had undergone any type of regenerative periodontal therapy, bisphosphonate or anti-resorptive drug therapy 6 months prior to the initial examination. 2)Patients with any systemic illness. 3)Patients who are pregnant or lactating, allergic to materials and drugs used or prescribed in this study. 4)History of smoking and alcohol.

Design outcomes

Secondary

Measure	Time frame
reduction in pocket depth and clinical attachment loss and bleeding on probingTimepoint: 6 months	—

Primary

Measure	Time frame
To assess the new bone formation ,bone volume, density and height in intrabony defects.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactP. Aravind kumar

st.joseph dental college

pavuluriak@gamil.com9948544799

Outcome results